• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA.

作者信息

Chedid Marcio F

机构信息

Liver and Pancreas Transplant and Hepatobiliary Surgery Unit, Hospital de Clinicas de Porto Alegre (HCPA), Federal University of Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos 2350, Sixth Floor, Room 600, Porto Alegre, 90035-903, Brazil.

出版信息

Dig Dis Sci. 2017 Oct;62(10):2621-2622. doi: 10.1007/s10620-017-4724-6.

DOI:10.1007/s10620-017-4724-6
PMID:28840385
Abstract
摘要

相似文献

1
Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA.非酒精性脂肪性肝炎：美国肝脏移植的第二大主要适应症。
Dig Dis Sci. 2017 Oct;62(10):2621-2622. doi: 10.1007/s10620-017-4724-6.
2
De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation.肝移植后非酒精性脂肪性肝炎的新发与复发
Clin Liver Dis. 2017 May;21(2):321-335. doi: 10.1016/j.cld.2016.12.006. Epub 2017 Feb 1.
3
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.非酒精性脂肪性肝病和非酒精性脂肪性肝炎：肝移植的相关影响。
Liver Transpl. 2018 Feb;24(2):166-170. doi: 10.1002/lt.25003.
4
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.非酒精性脂肪性肝病/非酒精性脂肪性肝炎在肝移植中的应用。
Clin Liver Dis. 2018 Feb;22(1):213-227. doi: 10.1016/j.cld.2017.08.015. Epub 2017 Oct 6.
5
The role of extended criteria donors in liver transplantation for nonalcoholic steatohepatitis.扩大标准供体在非酒精性脂肪性肝炎肝移植中的作用。
Surgery. 2016 Dec;160(6):1533-1543. doi: 10.1016/j.surg.2016.06.051. Epub 2016 Aug 21.
6
Nonalcoholic Steatohepatitis Is Becoming a Top Indication for Liver Transplantation Worldwide.非酒精性脂肪性肝炎正成为全球肝移植的首要适应症。
Liver Transpl. 2019 Jan;25(1):10-11. doi: 10.1002/lt.25387.
7
Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.酒精性或非酒精性脂肪性肝炎所致肝硬化肝移植受者心血管事件的发生率及其对生存的影响
Exp Clin Transplant. 2016 Feb;14(1):79-85. doi: 10.6002/ect.2015.0089. Epub 2015 Nov 17.
8
Nonalcoholic fatty liver disease: a systematic review.非酒精性脂肪性肝病：系统评价。
JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370.
9
Liver transplantation and non-alcoholic fatty liver disease.肝移植与非酒精性脂肪性肝病
World J Gastroenterol. 2014 Nov 14;20(42):15532-8. doi: 10.3748/wjg.v20.i42.15532.
10
Sex differences in age at wait-list registration for liver transplantation with nonalcoholic steatohepatitis as primary indication.以非酒精性脂肪性肝炎为主要指征的肝移植等待名单登记年龄的性别差异。
Clin Transplant. 2021 Feb;35(2):e14163. doi: 10.1111/ctr.14163. Epub 2020 Dec 6.

引用本文的文献

1
Advanced Liver Fibrosis Impairs Cardiorespiratory Fitness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.晚期肝纤维化损害代谢功能障碍相关脂肪性肝病患者的心肺适能。
Dig Dis Sci. 2025 Apr;70(4):1530-1539. doi: 10.1007/s10620-025-08893-4. Epub 2025 Feb 18.
2
Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.补充姜黄素对非酒精性脂肪性肝病患者肝酶的治疗作用：一项随机临床试验的系统评价和荟萃分析
Food Sci Nutr. 2024 Dec 1;13(1):e4144. doi: 10.1002/fsn3.4144. eCollection 2025 Jan.
3

本文引用的文献

1
Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.美国非酒精性脂肪性肝炎的肝移植：时间趋势与结局
Dig Dis Sci. 2017 Oct;62(10):2915-2922. doi: 10.1007/s10620-017-4684-x. Epub 2017 Jul 25.
2
Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.当前直接作用抗病毒方案在丙型肝炎肾移植和肝移植受者中的安全性和有效性：HCV-TARGET研究结果
Hepatology. 2017 Oct;66(4):1090-1101. doi: 10.1002/hep.29258. Epub 2017 Sep 4.
3
De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation.
Percutaneous ethanol injection is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation.
经皮乙醇注射是肝移植前治疗肝细胞癌的一种可接受的桥接治疗方法。
Langenbecks Arch Surg. 2023 Jan 14;408(1):26. doi: 10.1007/s00423-022-02750-y.
4
The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1.抗纤维化药物吡非尼酮通过作用于小氧化还原酶谷氧还蛋白-1来抑制肝纤维化。
Sci Adv. 2021 Sep 3;7(36):eabg9241. doi: 10.1126/sciadv.abg9241. Epub 2021 Sep 1.
5
The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study.非肥胖型非酒精性脂肪性肝病患者患2型糖尿病和冠状动脉疾病的风险：一项队列研究
Front Cardiovasc Med. 2021 Aug 20;8:680664. doi: 10.3389/fcvm.2021.680664. eCollection 2021.
6
Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.4-甲基伞形酮抑制透明质酸合成可改善胆碱缺乏 L-氨基酸定义饮食诱导的小鼠非酒精性脂肪性肝炎模型。
Arch Pharm Res. 2021 Feb;44(2):230-240. doi: 10.1007/s12272-021-01309-7. Epub 2021 Jan 24.
7
Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study.非肥胖中国人群中丙氨酸氨基转移酶/天冬氨酸氨基转移酶比值与新发非酒精性脂肪性肝病的关系：一项基于人群的纵向研究。
Lipids Health Dis. 2020 Nov 25;19(1):245. doi: 10.1186/s12944-020-01419-z.
8
Liver Transplantation for Alcohol-Related Liver Disease (ARLD): An Update on Controversies and Considerations.肝移植治疗酒精相关肝病（ARLD）：争议与关注点的最新进展。
Can J Gastroenterol Hepatol. 2020 Sep 17;2020:8862152. doi: 10.1155/2020/8862152. eCollection 2020.
9
Metabolic Profiling Reveals Aggravated Non-Alcoholic Steatohepatitis in High-Fat High-Cholesterol Diet-Fed Apolipoprotein E-Deficient Mice Lacking Ron Receptor Signaling.代谢谱分析揭示了缺乏Ron受体信号的高脂高胆固醇饮食喂养的载脂蛋白E缺陷小鼠中，非酒精性脂肪性肝炎病情加重。
Metabolites. 2020 Aug 11;10(8):326. doi: 10.3390/metabo10080326.
10
Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis.血脂异常是非酒精性脂肪性肝炎患者肝纤维化进展的一个危险因素。
F1000Res. 2020 Jan 28;9:56. doi: 10.12688/f1000research.21918.1. eCollection 2020.
肝移植后非酒精性脂肪性肝炎的新发与复发
Clin Liver Dis. 2017 May;21(2):321-335. doi: 10.1016/j.cld.2016.12.006. Epub 2017 Feb 1.
4
Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.美国青少年和青年中慢性肝病负担日益加重：一场无声的流行病。
Dig Dis Sci. 2017 May;62(5):1373-1380. doi: 10.1007/s10620-017-4492-3. Epub 2017 Feb 13.
5
DIETARY MANAGEMENT FOR DYSLIPIDEMIA IN LIVER TRANSPLANT RECIPIENTS.肝移植受者血脂异常的饮食管理
Arq Bras Cir Dig. 2016 Nov-Dec;29(4):246-251. doi: 10.1590/0102-6720201600040008.
6
Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors.通过合理使用来自七十多岁和八十多岁已故捐赠者的肝脏，患者和移植物有望获得出色的长期存活。
HPB (Oxford). 2014 Sep;16(9):852-8. doi: 10.1111/hpb.12221. Epub 2014 Jan 28.
7
The global NAFLD epidemic.全球非酒精性脂肪性肝病流行状况。
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):686-90. doi: 10.1038/nrgastro.2013.171. Epub 2013 Sep 17.
8
Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease.联合肝移植和胃袖状切除术治疗肥胖合并终末期肝病的患者。
Am J Transplant. 2013 Feb;13(2):363-8. doi: 10.1111/j.1600-6143.2012.04318.x. Epub 2012 Nov 8.
9
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.美国非酒精性脂肪性肝炎患者进行肝移植的频率和结果。
Gastroenterology. 2011 Oct;141(4):1249-53. doi: 10.1053/j.gastro.2011.06.061. Epub 2011 Jul 2.
10
The impact of disease recurrence on graft survival following liver transplantation: a single centre experience.疾病复发对肝移植后移植物存活的影响：单中心经验
Transpl Int. 2008 May;21(5):459-65. doi: 10.1111/j.1432-2277.2007.00628.x. Epub 2008 Jan 21.